Sung‐Youl Ko

4.6k total citations
21 papers, 1.4k citations indexed

About

Sung‐Youl Ko is a scholar working on Immunology, Virology and Epidemiology. According to data from OpenAlex, Sung‐Youl Ko has authored 21 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 9 papers in Virology and 6 papers in Epidemiology. Recurrent topics in Sung‐Youl Ko's work include Immune Cell Function and Interaction (12 papers), HIV Research and Treatment (9 papers) and Immunotherapy and Immune Responses (8 papers). Sung‐Youl Ko is often cited by papers focused on Immune Cell Function and Interaction (12 papers), HIV Research and Treatment (9 papers) and Immunotherapy and Immune Responses (8 papers). Sung‐Youl Ko collaborates with scholars based in United States, South Korea and Japan. Sung‐Youl Ko's co-authors include Chang‐Yuil Kang, Hyun‐Jeong Ko, Mi–Na Kweon, Se‐Ho Park, Yeon‐Jeong Kim, Gary J. Nabel, Taisuke Horimoto, Sanghee Kim, Woo-Sung Chang and Yun-Sun Kim and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Sung‐Youl Ko

21 papers receiving 1.3k citations

Peers

Sung‐Youl Ko

IMMUN

VIROL

EPIDE

Ellis van Liempt Netherlands

Mary Schaefer United States

J. Mauricio Calvo‐Calle United States

Tracy J. Ruckwardt United States

Shelley Stewart United States

Marie‐France del Guercio United States

Hélène Gras-Masse France

Frédéric Martinon France

Karl Deres Germany

Stefano Buttò Italy

Ellis van Liempt Netherlands

Sung‐Youl Ko

1.0k ×1.2

IMMUN

112 ×0.3

VIROL

555 ×1.8

292 ×1.1

EPIDE

189 ×0.9

Citations per year, relative to Sung‐Youl Ko Sung‐Youl Ko (= 1×) peers Ellis van Liempt

Countries citing papers authored by Sung‐Youl Ko

Since Specialization

Citations

This map shows the geographic impact of Sung‐Youl Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung‐Youl Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung‐Youl Ko more than expected).

Fields of papers citing papers by Sung‐Youl Ko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung‐Youl Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung‐Youl Ko. The network helps show where Sung‐Youl Ko may publish in the future.

Co-authorship network of co-authors of Sung‐Youl Ko

This figure shows the co-authorship network connecting the top 25 collaborators of Sung‐Youl Ko. A scholar is included among the top collaborators of Sung‐Youl Ko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sung‐Youl Ko. Sung‐Youl Ko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

King, Hannah A. D., Sung‐Youl Ko, Christine M. Fennessey, et al.. (2025). Antibody prophylaxis may mask subclinical SIV infections in macaques. Nature. 639(8053). 205–213. 1 indexed citations

Boswell, Kristin L., David R. Ambrozak, Rosemarie D. Mason, et al.. (2023). Rhesus macaque Bcl-6/Bcl-xL B cell immortalization: Discovery of HIV-1 neutralizing antibodies from lymph node. Journal of Immunological Methods. 516. 113445–113445. 1 indexed citations

Cheng, Cheng, Lingshu Wang, Sung‐Youl Ko, et al.. (2015). Combination recombinant simian or chimpanzee adenoviral vectors for vaccine development. Vaccine. 33(51). 7344–7351. 15 indexed citations

Pegu, Amarendra, Zhi-Yong Yang, Jeffrey C. Boyington, et al.. (2014). Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor. Science Translational Medicine. 6(243). 243ra88–243ra88. 169 indexed citations

Doria‐Rose, Nicole A., Rachel M. Klein, Stephen A. Migueles, et al.. (2012). Antibody-Dependent Cellular Cytotoxicity against Primary HIV-Infected CD4⁺T Cells Is Directly Associated with the Magnitude of Surface IgG Binding. Journal of Virology. 86(16). 8672–8680. 84 indexed citations

Ko, Sung‐Youl, Timothy Kuo, Richard S. Blumberg, & Gary J. Nabel. (2011). Modification of VRC01 for enhancing half-life and ADCC activity (155.39). The Journal of Immunology. 186(1_Supplement). 155.39–155.39. 1 indexed citations

Wang, Lingshu, Cheng Cheng, Sung‐Youl Ko, et al.. (2009). Delivery of Human Immunodeficiency Virus Vaccine Vectors to the Intestine Induces Enhanced Mucosal Cellular Immunity. Journal of Virology. 83(14). 7166–7175. 19 indexed citations

Kong, Wing-Pui, Lan Wu, Timothy C. Wallstrom, et al.. (2008). Expanded Breadth of the T-Cell Response to Mosaic Human Immunodeficiency Virus Type 1 Envelope DNA Vaccination. Journal of Virology. 83(5). 2201–2215. 54 indexed citations

Nguyen, Huan Huu, Nicolas Çuburu, Taisuke Horimoto, et al.. (2008). Sublingual vaccination with influenza virus protects mice against lethal viral infection. Proceedings of the National Academy of Sciences. 105(5). 1644–1649. 167 indexed citations

10.

Ko, Sung‐Youl, Cheng Cheng, Wing-Pui Kong, et al.. (2008). Enhanced Induction of Intestinal Cellular Immunity by Oral Priming with Enteric Adenovirus 41 Vectors. Journal of Virology. 83(2). 748–756. 20 indexed citations

11.

Ko, Hyun‐Jeong, Yeon‐Jeong Kim, Yun-Sun Kim, et al.. (2007). A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model. Cancer Research. 67(15). 7477–7486. 165 indexed citations

12.

Ko, Sung‐Youl, Kyoo‐A Lee, Hyun‐Jeong Ko, et al.. (2007). A single intranasal immunization with inactivated influenza virus and α-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system. Vaccine. 25(28). 5189–5198. 77 indexed citations

13.

Ko, Sung‐Youl, Kyoo‐A Lee, Yeon‐Jeong Kim, et al.. (2007). Mediastinal lymph node CD8α⁻ DC initiate antigen presentation following intranasal coadministration of α‐GalCer. European Journal of Immunology. 37(8). 2127–2137. 11 indexed citations

14.

Lee, Tae‐Ho, Sung‐Youl Ko, Dong Jae Baek, et al.. (2007). Synthesis and Evaluation of 1,2,3-Triazole Containing Analogues of the Immunostimulant α-GalCer. Journal of Medicinal Chemistry. 50(3). 585–589. 156 indexed citations

15.

Chung, Yeonseok, Byung Seok Kim, Yeon‐Jeong Kim, et al.. (2006). CD1d-Restricted T Cells License B Cells to Generate Long-Lasting Cytotoxic Antitumor Immunity In vivo. Cancer Research. 66(13). 6843–6850. 59 indexed citations

16.

Chung, Yeonseok, Sung‐Youl Ko, Hyun‐Jeong Ko, & Chang‐Yuil Kang. (2005). Split peripheral tolerance: CD40 ligation blocks tolerance induction for CD8 T cells but not for CD4 T cells in response to intestinal antigens. European Journal of Immunology. 35(5). 1381–1390. 9 indexed citations

17.

Ko, Hyun‐Jeong, et al.. (2005). Optimization of Codon Usage Enhances the Immunogenicity of a DNA Vaccine Encoding Mycobacterial Antigen Ag85B. Infection and Immunity. 73(9). 5666–5674. 54 indexed citations

18.

Ko, Sung‐Youl, Hyun‐Jeong Ko, Woo-Sung Chang, et al.. (2005). α-Galactosylceramide Can Act As a Nasal Vaccine Adjuvant Inducing Protective Immune Responses against Viral Infection and Tumor. The Journal of Immunology. 175(5). 3309–3317. 157 indexed citations

19.

Chang, Sun Young, et al.. (2004). Enhanced efficacy of DNA vaccination against Her‐2/neu tumor antigen by genetic adjuvants. International Journal of Cancer. 111(1). 86–95. 45 indexed citations

20.

Ko, Sung‐Youl, Mi-Ra Lee, Jae‐Ouk Kim, et al.. (2003). Comparative analysis of effects of cytokine gene adjuvants on DNA vaccination against Mycobacterium tuberculosis heat shock protein 65. Vaccine. 21(25-26). 3684–3689. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact